68
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

Emerging role of Alemtuzumab in renal and renal–pancreas transplantation

, MD FRCP, , MD, , DO & , MD
Pages 1605-1625 | Published online: 07 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ronald F Parsons, Kumar Vivek, Robert R Redfield, Thi-Sau Migone, Michael P Cancro, Ali Naji & Hooman Noorchashm. (2009) B-cell tolerance in transplantation: is repertoire remodeling the answer?. Expert Review of Clinical Immunology 5:6, pages 703-723.
Read now

Articles from other publishers (5)

Marcelo S. Sampaio, Bhavna Chopra & Kalathil K. Sureshkumar. (2017) Depleting Antibody Induction and Kidney Transplant Outcomes. Transplantation 101:10, pages 2527-2535.
Crossref
Jesse Schold, Emilio Poggio, David Goldfarb, Liise Kayler & Stuart Flechner. (2015) Clinical Outcomes Associated With Induction Regimens Among Retransplant Kidney Recipients in the United States. Transplantation 99:6, pages 1165-1171.
Crossref
T. Noureldeen, Z. Albekioni, L. Machado, N. Muddana, R.J. Marcus, S.M. Hussain & K.K. Sureshkumar. (2014) Alemtuzumab Induction and Antibody-Mediated Rejection in Kidney Transplantation. Transplantation Proceedings 46:10, pages 3405-3407.
Crossref
Hao Zhou, Jian Lin, Shushang Chen, Liqiang Ma, Zhenzhen Qiu, Weidong Chen, Xin’an Zhang, Yi Zhang & Xiuquan Lin. (2012) Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation. Clinical and Experimental Nephrology 17:2, pages 304-309.
Crossref
Kalathil K. Sureshkumar, Ngoc L. Thai, Sabiha M. Hussain, Tina Y. Ko & Richard J. Marcus. (2012) Influence of Induction Modality on the Outcome of Deceased Donor Kidney Transplant Recipients Discharged on Steroid-Free Maintenance Immunosuppression. Transplantation 93:8, pages 799-805.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.